• AG真人国际(中国)官方官网

    |
    |
    EN
    • 业务咨询

      中国:

      Email: marketing@videisimo.net

      业务咨询专线:400-780-8018

      (仅限服务咨询,其他事宜请拨打川沙总部电话)

      川沙总部电话: +86 (21) 5859-1500

      海外:

      +1(626)986-9880(U.S. - West Coast)

      0044 7790 816 954 (Europe)

      Email:marketing@medicilon.com

    在线留言×
    点击切换
    News information
    新闻资讯

    【一期一会】冬天想好去哪了吗?开往12月的AG真人国际(中国)官方官网会议列车,快来Join吧!

    2023-12-05
    |
    访问量:

    Tips

    AG真人国际(中国)官方官网汇总整理了12月生物医药行业会议供参考交流。同时,我们将计划参与海内外5场会议:

    - “SLAS-ELRIG Networking Event”

    - “Genesis 2023”

    - "Mediclon Boston Opening"

    - “ASH 2023”

    - “2023深圳湾实验室转化医学高峰论坛”

    marketing@videisimo.net.jpg

    marketing@videisimo.net
    媒体与会务请联系微信或邮箱

    01  
    2023/12/5

    SLAS-ELRIG Networking Event

    1 SLAS-ELRIG Networking Event.jpg

    Ready to Meet Medicilon at SLAS-ELRIG Networking Event?

    Revolutionary Adhesion: Unveiling the Power of Molecular Glues in Medicine, Science and Beyond!

    We are happy to meet you in person to discuss how our services and capabilities can support your research and expedite your drug discovery and development activities.

    Proteolysis targeting chimeras (PROTACs) offer a fast and reversible chemical knock-down approach to control protein function. PROTAC technology takes advantage of a moiety of targeted protein and a moiety of recognizing E3 ubiquitin ligase and produces a hybrid molecule to specifically knock down a targeted protein.

    Medicilon provides PROTAC drug discovery, CMC research (API + formulation), pharmacodynamics research, PK study, safety evalsuation and other services. Medicilon’s PROTAC drug discovery technology platform covers the currently popular target protein ligands. We have established a linker system with an extensive collection of bifunctional linkers. Together with our expanding E3 ubiquitin ligase binder library, we can efficiently synthesize a substantial amount of highly active PROTAC bispecific small molecules, which would have the potential to significantly facilitate the drug discovery and development process. As of the end of June 2023, Medicilon has successfully assisted in the clinical approval of 5 PROTAC drugs and has 20+ PROTAC projects under development.

    Date: Tuesday 5 December 2023 from 10:00 -18:00

    locations: 1 Wimpole Street, London, W1G 0AE

    02
    2023/12/7

    Genesis 2023

    2 Genesis 2023.jpg

    Join Medicilon at Genesis 2023!

    Fostering Innovation, Investment, and Deal-making at Genesis 2023.

    For over two decades, the annual Genesis conference has brought key Life Science opinion leaders and stakeholders together to debate key trends, instigate deals and generate a vision of the future.

    By facilitating critical networking, and sharing the latest insights in the Life Sciences industry, One Nucleus' Genesis 2023 & Genesis Fringe Seminars can help you and your organization along your journey to success. 300 delegates from across the industry attend Genesis, and this year is expected to achieve the same on 5-8 December in Central London. Between the insightful keynote sessions are valuable breaks where you can continue the exciting stimulating discussions, and meet contacts old and new.

    Dr. Jing Deng, our VP of Pharmacology, Pharmacodynamics and Biology Department, will give a great presentation titled "New technology platforms in preclinical research" in Genesis Fringe Seminar on December 5th, 2023, 18:00-21:00 pm.

    03
    2023/12/7-8
    广州

    InnoXBio首届大湾区细胞基因治疗发展论坛

    3 InnoXBio首届大湾区细胞基因治疗发展论坛.jpg

    InnoXBio生物医药产业生态圈大会暨首届大湾区细胞基因治疗发展论坛定于2023年12月7-8日,在广州知识城国际会展中心召开,大会将邀请CGT产业上下游行业专家,以主题演讲、圆桌讨论、产品展示等形式分享行业成果与前沿动态,把握产业发展脉搏,携手各方,共筑产业兴!

    04
    2023/12/9

    Mediclon Boston Opening

    4 Mediclon Boston Opening.jpg

    Celebrate Mediclon Boston Opening!

    Medicilon is an integrated contract research organization (CRO), providing comprehensive one-stop new drug R&D service for pharmaceutical enterprises and scientific research institutions around the world. We are excited to invite you to the Medicilon Boston Site Opening Reception for a great time of lunch, networking, and discussion.

    The theme of this event is to share hopes and bright future of biomedicine. With the opening its Boston site, Medicilon is committed to working ever closely with our partners in their pursuit of finding cures for patients in need.

    Date: December 9th, 2023 (Saturday)

    Time:11:00 am - 2:00 pm

    Venue: Medicilon Boston Site (50 Soldiers Field Place, Boston, MA 02135)

    05
    2023/12/9-12

    ASH 2023

    5 ASH 2023.jpg

    We look forward to meeting you at ASH 2023!

    With more than 18,000 members from nearly 100 countries, ASH is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases. Fostering high-quality, equitable care, transformative research, and innovative education to improve the lives of patients with blood and bone marrow disorders.

    Medicilon team are present throughout the conference.

    Medicilon translational medicine platform is committed to providing global partners with comprehensive biomarker discovery, target integrated solutions for point-of-care verification, companion diagnostic development, and commercial testing.

    We look forward to welcoming you in San Diego!

    Date: December 9-12, 2023

    locations: San Diego

    06
    2023/12/10
    深圳

    2023深圳生物医药产业创新与发展高峰论坛会

    6 2023深圳生物医药产业创新与发展高峰论坛.jpg

    由深圳市坪山区科技创新局指导,南方科技大学坪山生物医药研究院和化学化工专业委员会联合主办,深圳市坪山区小分子新药创联协会、药渡经纬信息科技(北京)有限公司、银星坪山生命健康科技园联合承办,深圳市坪山区产业资本投资有限公司、贝壳学社、深圳市生命科学与生物技术协会、深圳市坪山区高层次人才协会、深圳市华先医药科技有限公司、深圳艾欣达伟医药科技有限公司、深圳安泰维生物医药有限公司、深圳格林凯特医药技术有限公司、化学加联合协办的“2023深圳生物医药产业创新发展高峰论坛暨化学化工专业委员会年会”,拟定于2023年12月10日在深圳市坪山银星生命健康产业园举办。

    07
    2023/12/11
    深圳

    2023深圳湾实验室转化医学高峰论坛

    7 2023深圳湾实验室转化医学高峰论坛.jpg

    本次会议以“医药创新加速、转化助力共赢”为主题,汇聚国内外有实战转化经验的科研院所、创新药企、生物科技公司、投资公司、CXO等生态群体,助力科研机构医药创新与转化,致力于打造中国医药创新和转化领域顶尖的行业盛会。

    参会嘉宾将就“新型科研机构如何进行转化”“医药资本市场对创新药开发方向”“创新药源头开发策略”以及“科研机构如何同药企进行更好的合作”等问题共同思考、分享实践、探寻方法。

    08
    2023/12/14-16

    2023首届长三角生物医药产业大会

    8 2023首届长三角生物医药产业大会.jpg

    由长三角企业家联盟、浙江省工商业联合会指导,杭州市滨江区人民政府、长三角数据驱动创新生物医药产业链联盟、中国生物医药产业链创新转化联合体主办,火石数链、贝达药业、南京生物医药创新转化中心、药咖荟承办的“长三角生物医药产业大会”将于2023年12月14-16日在杭州召开。

    本次大会以“数智时代 医药生存与创新”为主题,整合长三角地区IT+BT资源,交流探讨数字技术赋能生物医药产业数字化转型新路径与新经验,推进产业大数据及数字技术在药物发现、设计、研发、临床研究、质量检测、全链条管理等数字化场景应用创新。通过数据驱动+产业互联,把产业数字化治理与药械企业创新生态构建相结合,以数据流带动业务流,推动数据要素价值化,医药营销合规化,打造服务全国的产业服务交流平台,实现数据驱动全要素生产率和医药产业资源配置效率的提升,助力长三角数字化发展之路走深走实,共筑产业新生态。

    09
    2023/12/16-17

    第二届中国•宁波生物医药产业发展大会

    9 第二届中国•宁波生物医药产业发展大会.jpg

    生物医药作为中国七大战略性新兴产业之一,是健康中国建设的重要基础,也是宁波市重点聚焦的战略性新兴产业。为深入推进生物医药产业高质量快速发展,优化全球临床开发和跨境合作,促进技术成果推介和供需对接,“第二届中国•宁波生物医药产业发展大会”暨“第三届新药创业在前湾项目路演&投融资洽谈会”将于2023年12月15-17日在前湾新区宁波杭州湾凯悦酒店举办。

    会议将围绕创新药研发、细胞基因疗法、AI与合成生物学、小核酸药物研发、中药现代化等专题进行探讨交流,深度融合行业资源和产业资本,共同推进生物医药产业的蓬勃发展。诚挚地邀请您拨冗出席本次盛会!

    10
    2023/12/27-28
    北京

    2023创新药华北峰会

    10 2023创新药华北峰会.jpg

    作为中国生物医药四大聚集地之一,京津冀地区已成为我国生物医药产业发展重要集聚地之一,初步形成了以北京为核心、天津和河北互补协作的产业协同发展格局。其中北京生物医药产业创新优势突出,初步形成了“一南一北、各具特色”的空间布局。“南”包括以亦庄和大兴生物医药基地为核心的高端产业基地,“北”包括以中关村生命科学园为核心的研发创新中心。

    其中RNA疗法产业华北论坛将聚焦RNA疗法突破,关注小核酸药物开发、mRNA新型传染病疫苗、mRNA新型癌症疫苗等产品的开发,大会将于12月27日-28日在北京举办,基于前三届RNA疗法与新型疫苗产业峰会,本次峰会将吸引超过1300人次参会嘉宾。

    marketing@videisimo.net.jpg

    marketing@videisimo.net
    微信或邮件AG真人国际(中国)官方官网

    相关新闻